排序方式: 共有31条查询结果,搜索用时 0 毫秒
1.
2.
3.
4.
5.
6.
Francis Lau PhD Vincent Maida MD Michael Downing MD Mary Lesperance PhD PStat Nicholas Karlson PhD Craig Kuziemsky PhD 《Journal of pain and symptom management》2009,37(6):965-972
This study examines the use of the Palliative Performance Scale (PPS) in end-of-life prognostication within a regional palliative care program in a Canadian province. The analysis was done on a prospective cohort of 513 patients assessed by a palliative care consult team as part of an initial community/hospital-based consult. The variables used were initial PPS score, age, gender, diagnosis, cancer type, and survival time. The findings revealed initial PPS to be a significant predictor of survival, along with age, diagnosis, cancer type and site, but not gender. The survival curves were distinct for PPS 10%, 20%, and 30% individually, and for 40%–60% and ≥70% as bands. This is consistent with earlier findings of the ambiguity and difficulty when assessing patients at higher PPS levels because of the subjective nature of the tool. We advocate the use of median survival and survival rates based on a local cohort where feasible, when reporting individual survival estimates. 相似文献
7.
8.
9.
Patterns of medical management of overactive bladder (OAB) and benign prostatic hyperplasia (BPH) in the United States
下载免费PDF全文
![点击此处可从《Neurourology and urodynamics》网站下载免费的PDF全文](/ch/ext_images/free.gif)
10.
Systematic literature review of clinical trials evaluating pharmacotherapy for overactive bladder in elderly patients: An assessment of trial quality
下载免费PDF全文
![点击此处可从《Neurourology and urodynamics》网站下载免费的PDF全文](/ch/ext_images/free.gif)
Kristin D. Kistler PhD Yingxin Xu PharmD PhD Kelly H. Zou PhD PStat® Fady Ntanios PhD Douglass S. Chapman MS Xuemei Luo PhD 《Neurourology and urodynamics》2018,37(1):54-66